Walter Cosolo

722 total citations
22 papers, 581 citations indexed

About

Walter Cosolo is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Walter Cosolo has authored 22 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Walter Cosolo's work include Cancer Treatment and Pharmacology (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Walter Cosolo is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Walter Cosolo collaborates with scholars based in Australia, Ukraine and Spain. Walter Cosolo's co-authors include John Zalcberg, N. Christophidis, Denis J. Morgan, Paul Martinello, W. J. Louis, Jo‐anne E Brien, Sreeni Yalamanchili, Elizabeth A. Punnoose, Iryna Dyagil and Halyna Pylypenko and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

Walter Cosolo

20 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walter Cosolo Australia 12 178 175 122 86 58 22 581
Karen A. Osborne United States 10 149 0.8× 132 0.8× 216 1.8× 55 0.6× 48 0.8× 17 861
J.L. Misset France 13 121 0.7× 357 2.0× 124 1.0× 55 0.6× 45 0.8× 39 733
Angela Men United States 8 125 0.7× 206 1.2× 69 0.6× 129 1.5× 53 0.9× 12 597
Salman Gailani United States 15 187 1.1× 255 1.5× 162 1.3× 61 0.7× 43 0.7× 38 743
Lauro José Gregianin Brazil 18 170 1.0× 209 1.2× 264 2.2× 36 0.4× 75 1.3× 66 665
Jacqueline Stone United States 9 161 0.9× 149 0.9× 209 1.7× 106 1.2× 25 0.4× 19 702
Richard D. Lopez United States 21 183 1.0× 422 2.4× 89 0.7× 73 0.8× 26 0.4× 47 1.1k
Daniela Rizzo Italy 17 182 1.0× 102 0.6× 130 1.1× 129 1.5× 138 2.4× 37 705
Donna Griebel United States 12 105 0.6× 152 0.9× 176 1.4× 41 0.5× 69 1.2× 20 686
Wenze Wang China 19 251 1.4× 252 1.4× 167 1.4× 52 0.6× 43 0.7× 76 1.1k

Countries citing papers authored by Walter Cosolo

Since Specialization
Citations

This map shows the geographic impact of Walter Cosolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Cosolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Cosolo more than expected).

Fields of papers citing papers by Walter Cosolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Cosolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Cosolo. The network helps show where Walter Cosolo may publish in the future.

Co-authorship network of co-authors of Walter Cosolo

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Cosolo. A scholar is included among the top collaborators of Walter Cosolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Cosolo. Walter Cosolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khalafallah, Alhossain A., et al.. (2017). Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study. European Journal of Cancer Care. 27(2). e12638–e12638. 5 indexed citations
2.
Kipps, Thomas J., Herbert Eradat, Sebastian Grosicki, et al.. (2015). A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia. Leukemia & lymphoma. 56(10). 2826–2833. 151 indexed citations
3.
Flinn, Ian W., Ulrich Jäger, Fritz Offner, et al.. (2014). DUO: A phase 3 trial of the PI3K-δ,γ inhibitor IPI-145 versusofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.. Journal of Clinical Oncology. 32(15_suppl). TPS7122–TPS7122. 2 indexed citations
4.
5.
Gill, Sanjeev, Walter Cosolo, Rebecca Herbertson, Salvatore U. Berlangieri, & Andrew M. Scott. (2009). Medullary carcinoma of the thyroid in a patient with colon cancer and a rising carcinoembryonic antigen level. Internal Medicine Journal. 39(4). 264–265.
6.
Brien, Jo‐anne E, Ego Seeman, John Zalcberg, et al.. (1998). Relationships among liver and kidney volumes, lean body mass and drug clearance. British Journal of Clinical Pharmacology. 46(5). 447–452. 54 indexed citations
7.
Millward, Michael, John Zalcberg, James F. Bishop, et al.. (1997). Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 15(2). 750–758. 69 indexed citations
8.
Brien, Jo‐anne E, et al.. (1997). Accuracy of Volume Measurement Using Helical CT. Journal of Computer Assisted Tomography. 21(3). 481–486. 66 indexed citations
9.
Buchanan, John, et al.. (1996). Patients' beliefs about cancer management. Supportive Care in Cancer. 4(2). 110–117. 21 indexed citations
10.
Cosolo, Walter, et al.. (1996). Classical Kaposi's: A rare cause of gastrointestinal haemorrhage. Journal of Gastroenterology and Hepatology. 11(4). 408–410. 5 indexed citations
11.
Siderov, Jim, et al.. (1995). Quality of pharmacokinetic research in oncology. British Journal of Cancer. 72(3). 792–794. 2 indexed citations
12.
Cosolo, Walter, et al.. (1994). Lean body mass, body surface area and epirubicin kinetics. Anti-Cancer Drugs. 5(3). 293–297. 28 indexed citations
13.
Zhang, Wenjing, John Zalcberg, & Walter Cosolo. (1992). Interaction of epirubicin with other cytotoxics and anti-emetic drugs. Anti-Cancer Drugs. 3(6). 593–598. 7 indexed citations
14.
Cosolo, Walter, et al.. (1992). Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo.. PubMed. 30(12). 576–81. 13 indexed citations
15.
Cosolo, Walter, et al.. (1991). Interaction of cisplatin with other cytotoxics and non-steroidal anti-inflammatory drugs. Anti-Cancer Drugs. 2(2). 169–174. 1 indexed citations
16.
Cosolo, Walter, Olaf H. Drummer, & N. Christophidis. (1989). Comparison of high-performance liquid chromatography and the Abbott Fluorescent Polarization Radioimmunoassay in the measurement of methotrexate. Journal of Chromatography B Biomedical Sciences and Applications. 494. 201–208. 13 indexed citations
17.
Cosolo, Walter, Paul Martinello, W. J. Louis, & N. Christophidis. (1989). Blood-brain barrier disruption using mannitol: time course and electron microscopy studies. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 256(2). R443–R447. 82 indexed citations
18.
Cosolo, Walter, et al.. (1988). Flare Responses in Small Cell Carcinoma of the Lung. Clinical Nuclear Medicine. 13(1). 13–16. 17 indexed citations
19.
Cosolo, Walter & N. Christophidis. (1987). Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.. PubMed. 47(23). 6225–8. 14 indexed citations
20.
Christophidis, N., et al.. (1984). The effect of penicillamine and related thiols on cyclophosphamide-induced cystitis and bone marrow suppression.. PubMed. 6(6). 493–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen A. Osborne Breakdown of academic impact, for papers by J.L. Misset Breakdown of academic impact, for papers by Angela Men Breakdown of academic impact, for papers by Salman Gailani Breakdown of academic impact, for papers by Lauro José Gregianin Breakdown of academic impact, for papers by Jacqueline Stone Breakdown of academic impact, for papers by Richard D. Lopez Breakdown of academic impact, for papers by Daniela Rizzo Breakdown of academic impact, for papers by Donna Griebel Breakdown of academic impact, for papers by Wenze Wang
Rankless by CCL
2026